Medicinal Prospects of Targeting Tyrosinase: A Feature Review

Curr Med Chem. 2023;30(23):2638-2671. doi: 10.2174/0929867329666220915123714.

Abstract

Tyrosinase is a bifunctional polyphenol oxidase (PPO), catalyzing two oxidative reactions: monophenols to o-quinones (monophenolase activity) and o-diphenols to oquinones (diphenolase activity). As tyrosinase is the rate-limiting enzyme for the melanogenesis process, it is an attractive target for melanogenesis inhibition. Aiming at skin whitening, anticancer, Parkinson's disease (PD) treatment, antibacterial, fruit and vegetable preservation and other anti-pigmentation effect, medicinal chemists have exploited diverse tyrosinase inhibitors through various approaches. In addition to discovering inhibitors with novel scaffolds, good activity and high safety, researchers also focused on developing strategies for synergistic effects of multiple inhibitors and simultaneously regulating multiple targets to treat cancer or neurodegenerative diseases. This review focused on multiple natural and synthetic tyrosinase inhibitors, which could contribute to preventing fruit and vegetable browning, skin whitening, antibacterial, anticancer, Parkinson's Disease, etc.

Keywords: PD treatment; Tyrosinase inhibitors; antibacterial; anticancer; fruit and vegetable preservation; skin whitening.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Monophenol Monooxygenase*
  • Oxidation-Reduction
  • Parkinson Disease*
  • Quinones

Substances

  • Monophenol Monooxygenase
  • Anti-Bacterial Agents
  • Quinones
  • Enzyme Inhibitors